Gene · 728655
Papers1,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study. | Clin Exp Hepatol | 2023 | 37502440 | PubTator, text mining | PubMed |
| Current status of molecular diagnostic approaches using liquid biopsy. | J Gastroenterol | 2023 | 37470859 | PubTator, text mining | PubMed |
| Sparse Independence Component Analysis for Competitive Endogenous RNA Co-Module Identification in Liver Hepatocellular Carcinoma. | IEEE J Transl Eng Health Med | 2023 | 37465460 | PubTator, text mining | PubMed |
| Lnc-HULC, miR-122, and sirtulin-1 as potential diagnostic biomarkers for psoriasis and their association with the development of metabolic syndrome during the disease course. | Noncoding RNA Res | 2023 | 37455763 | PubTator, text mining | PubMed |
| Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets. | Cancers (Basel) | 2023 | 37444408 | PubTator, text mining | PubMed |
| LncRNAs associated with oxidative stress in diabetic wound healing: Regulatory mechanisms and application prospects. | Theranostics | 2023 | 37441585 | PubTator, text mining | PubMed |
| Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. | MedComm (2020) | 2023 | 37441462 | PubTator, text mining | PubMed |
| Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37435203 | PubTator, text mining | PubMed |
| Construction of a novel nomogram based on competing endogenous RNAs and tumor-infiltrating immune cells for prognosis prediction in elderly patients with colorectal cancer. | Discov Oncol | 2023 | 37428291 | PubTator, text mining | PubMed |
| Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management. | Cancer Manag Res | 2023 | 37426392 | PubTator, text mining | PubMed |
| Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications. | Cell Death Dis | 2023 | 37422448 | PubTator, text mining | PubMed |
| Long non‑coding RNA PTCSC3 suppresses triple‑negative breast cancer by downregulating long non‑coding RNA MIR100HG. | Oncol Lett | 2023 | 37415630 | PubTator, text mining | PubMed |
| GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway. | BMC Cancer | 2023 | 37407932 | PubTator, text mining | PubMed |
| Deciphering the mechanisms of action of progesterone in breast cancer. | Oncotarget | 2023 | 37395734 | PubTator, text mining | PubMed |
| Transcriptional regulation of Glis2 in hepatic fibrosis. | Exp Mol Med | 2023 | 37394585 | PubTator, text mining | PubMed |
| Long non-coding RNAs modulate tumor microenvironment to promote metastasis: novel avenue for therapeutic intervention. | Front Cell Dev Biol | 2023 | 37384249 | PubTator, text mining | PubMed |
| miR-145 as a Potential Biomarker and Therapeutic Target in Patients with Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 37373169 | PubTator, text mining | PubMed |
| Regulation of EMT Markers, Extracellular Matrix, and Associated Signalling Pathways by Long Non-Coding RNAs in Glioblastoma Mesenchymal Transition: A Scoping Review. | Biology (Basel) | 2023 | 37372103 | PubTator, text mining | PubMed |
| LncRNA NEAT1 promotes IL-6 secretion in monocyte-derived dendritic cells via sponging miR-365a-3p in systemic lupus erythematosus. | Epigenetics | 2023 | 37343193 | PubTator, text mining | PubMed |
| Comprehensive analysis of candidate signatures of long non-coding RNA LINC01116 and related protein-coding genes in patients with hepatocellular carcinoma. | BMC Gastroenterol | 2023 | 37340445 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/728655/papers?page=6